Prescription drug esomeprazole magnesium recalled for labeling error
Zydus Pharmaceuticals is recalling esomeprazole magnesium oral suspension because of an incorrect NDC number on package labeling. The affected product is lot M408002 distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall involving a minor labeling error (incorrect NDC number). No illnesses, injuries, or health hazards have been reported.
Plain-English summary
Zydus Pharmaceuticals (USA) Inc is recalling esomeprazole magnesium delayed-release oral suspension 40 mg due to a labeling error. The recalled product contains an incorrect NDC number printed on the packaging.
The affected product is esomeprazole magnesium 40 mg delayed-release oral suspension in single-dose sachets, lot M408002 with expiration date 05/31/2026. Approximately 4,404 packs were distributed nationwide in the United States under product NDC 68382-849-94.
The recalled product
- Product
- ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE MAGNESIUM)
- Brand
- ESOMEPRAZOLE MAGNESIUM
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc
- Category
- Drug — Prescription Medication
- Hazard
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot#: M408002
- Exp 05/31/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ESOMEPRAZOLE MAGNESIUM
- HighEsomeprazole Magnesium Oral Suspension Recalled for Degradation Products
FDA (Drugs) · 2025-05-28
- ModerateEsomeprazole Magnesium Recall for Failed Out-of-Specification Degradation Products
FDA (Drugs) · 2025-05-28
- ModeratePrescription esomeprazole magnesium capsules recalled for failed impurity specifications
FDA (Drugs) · 2023-11-29
- ModeratePrescription Drug Esomeprazole Out of Specification for Potency
FDA (Drugs) · 2022-10-05
- ModerateEsomeprazole Magnesium Capsules Recalled for Out-of-Specification Potency
FDA (Drugs) · 2022-10-05
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27